Target intelligence / Profile preview

Extracellular matrix-interacting wound cells

Molecular classification
Other
01

Overview

Extracellular matrix-interacting wound cells is a descriptive term rather than a specific molecular target or receptor. It refers to a heterogeneous population of cells, including fibroblasts, myofibroblasts, and macrophages, that play a central role in the wound healing process by interacting with the extracellular matrix (ECM) (Tracy et al., 2016). These cells utilize various surface receptors, such as integrins and CD44, to sense the mechanical and chemical properties of the ECM, which in turn regulates their migration, proliferation, and differentiation (Hinz, 2016). In chronic wounds or fibrotic diseases, the interaction between these cells and the ECM is often pathological, leading to impaired healing or excessive scar formation (Gurtner et al., 2008). While not a single drug target, these cells are the focus of therapeutic strategies that use growth factors like Becaplermin to stimulate repair or small molecules like Pirfenidone to inhibit fibrotic activity. The dynamic interplay between these cells and the ECM scaffold is essential for successful tissue regeneration and the restoration of skin integrity.

Other names
ECM-interacting cellsWound-healing fibroblastsMyofibroblastsActivated fibroblastsWound-associated cells
02

Mechanism of action

Modulation of cellular proliferation, migration, and differentiation via growth factor receptor activation (e.g., PDGFR) or inhibition of pro-fibrotic signaling pathways (e.g., TGF-beta/Smad) to regulate ECM deposition.

03

Biological functions

Wound healingCell adhesionExtracellular matrix organizationCell migrationTissue remodelingWound contraction
04

Disease associations

Chronic woundsFibrosisHypertrophic scarringKeloidsDiabetic foot ulcers
05

Safety considerations

Risk of hypertrophic scarringPotential for malignancy with prolonged growth factor therapyImpaired systemic wound healingOff-target effects on connective tissue
06

Interacting drugs

Becaplermin

3 more in the full profile.

07

Biomarkers

Alpha-smooth muscle actin (alpha-SMA)VimentinType I collagenFibronectinCD44

Beyond the preview

Go deeper on Extracellular matrix-interacting wound cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix-interacting wound cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call